Inventor · disambiguated record
Fernando J. R. Do Couto
Also filed as: DO COUTO FERNANDO J · DO COUTO FERNANDO J R
6 granted patents·3 pending applications·246 citations·filing 1992–2008
85Inventor score
Files withCANCER RES INST OF CONTRA COST3CANCER RES FUND OF CONTRACOSTA2CANCER RES FUND1DO COUTO FERNANDO J1
Top patents by PatentIndex Score
9 records- 0193US6309636B1Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptidesCANCER RES INST OF CONTRA COST·Filed 1995·Granted Oct 30, 2001·168 cites·13 claims
- 0272US5804187AModified antibodies with human milk fat globule specificityCANCER RES FUND OF CONTRACOSTA·Filed 1993·Granted Sep 8, 1998·29 cites·72 claims
- 0367US6315997B1Use of modified antibodies with human milk fat globule specificityCANCER RES FUND·Filed 1997·Granted Nov 13, 2001·28 cites·65 claims
- 0464US6936706B2Modified antibodies with human milk fat globule specificity and usesFiled 2001·Granted Aug 30, 2005·4 cites·73 claims
- 0558US7390635B2Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptidesCANCER RES INST OF CONTRA COST·Filed 2004·Granted Jun 24, 2008·0 cites·5 claims
- 0658US5792852APolynucleotides encoding modified antibodies with human milk fat globule specificityCANCER RES FUND OF CONTRACOSTA·Filed 1992·Granted Aug 11, 1998·17 cites·63 claims
- 0758US2009010848A1Recombinant Peptides Derived from the Mc3 Anti-BA46 Antibody, Methods of Use Thereof, and Methods of Humanizing Antibody PeptidesCANCER RES INST OF CONTRA COST·Filed 2008·Application pending·0 cites
- 0855US2002164339A1Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptidesFiled 2001·Application pending·0 cites
- 0953US2006216303A1Processes and products with modified antibodies of human milk fat globule specificityDO COUTO FERNANDO J·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →